Product NDC: | 43063-221 |
Proprietary Name: | citalopram hydrobromide |
Non Proprietary Name: | citalopram hydrobromide |
Active Ingredient(s): | 40 mg/1 & nbsp; citalopram hydrobromide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43063-221 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077032 |
Marketing Category: | ANDA |
Start Marketing Date: | 20041112 |
Package NDC: | 43063-221-90 |
Package Description: | 90 TABLET in 1 BOTTLE, PLASTIC (43063-221-90) |
NDC Code | 43063-221-90 |
Proprietary Name | citalopram hydrobromide |
Package Description | 90 TABLET in 1 BOTTLE, PLASTIC (43063-221-90) |
Product NDC | 43063-221 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | citalopram hydrobromide |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20041112 |
Marketing Category Name | ANDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | CITALOPRAM HYDROBROMIDE |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |